BOX
BOX CEO Levie and CFO Smith Sell $1.1M in Stock on Same Day
Two Box insiders sold a combined 32,000 Class A shares in open-market transactions on September 10, worth about $1.1 million.
Latest
MDGL
MADRIGAL CEO Sibold Sells $6.2M in Shares Above $527
President and CEO William Sibold sold about 11,583 Madrigal shares on 9 and 11 September for roughly $6.24 million, leaving 197,746 shares.
Leadership
IGNITIS GRUPE Loses Entire Board of Grid Unit ESO After Storm Fallout
The full board of Lithuanian distribution operator ESO resigns as of 30 September, a day after its CEO stepped down amid record storm damage; 2026 guidance is unchanged.
LAES
SEALSQ Doubles H1 Revenue to $11.2M as Losses Widen to $27.8M
The post-quantum chipmaker reaffirmed FY2026 revenue guidance of $27M to $36M and ended June with $486.1 million in cash.
NFE
NEW FORTRESS ENERGY Recapitalizes With 1-for-50 Reverse Split
An amended charter effective September 11, 2026 combines every 50 Class A shares into one, wipes out Class B stock and creates mandatorily convertible preferred.
ATAI
ATAIBECKLEY Delisted as 8-K Points to Completed Eli Lilly Takeover
AtaiBeckley's amended charter lists Eli Lilly's Indianapolis headquarters as its business address and cuts authorized stock to 100 shares.
CLS
CELESTICA Names Todd Ankenmann CFO as Chawla Takes New Global Markets Role
Long-serving finance chief Mandeep Chawla becomes Group President, Global Markets, with Todd Ankenmann stepping up as CFO on October 1, 2026.
AEHL
ANTELOPE ENTERPRISE Prices $6.0 Million Convertible Note at 20% Discount
The Nasdaq-listed Chinese livestreaming ecommerce firm will issue an 8% convertible note with no fixed maturity, convertible at 80% of the lowest three-day VWAP.
DPRO
DRAGANFLY Wins Canadian Armed Forces Drone Contract With 5,000-Unit Ceiling
Draganfly received a five-year Government of Canada contract for 100 tactical ISR drones, with options for 4,900 more worth about C$24.25 million.
ALLR
ALLARITY Sponsors $100M SPAC IPO Through Wholly-Owned Subsidiary
The clinical-stage cancer drug developer's Allarity Acquisition Corp. filed an S-1 for a $100 million unit IPO, with Allarity holding about 25% as sponsor.
TPST
TEMPEST THERAPEUTICS Raises $2.5M Upfront in Private Placement
The clinical-stage biotech is selling 3.1 million shares at $0.805 with two warrant tranches that could add about $5 million more.
IMMP
IMMUTEP Narrows Efti Strategy After TACTI-004 Failure, Blames Manufacturing
Immutep traces the failed TACTI-004 trial to structural differences in efti made at 2,000 L scale and refocuses on HNSCC with CPS < 1 and neoadjuvant sarcoma.